BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 30673302)

  • 1. Impact of different image reconstructions on PET quantification in non-small cell lung cancer: a comparison of adenocarcinoma and squamous cell carcinoma.
    Messerli M; Kotasidis F; Burger IA; Ferraro DA; Muehlematter UJ; Weyermann C; Kenkel D; von Schulthess GK; Kaufmann PA; Huellner MW
    Br J Radiol; 2019 Apr; 92(1096):20180792. PubMed ID: 30673302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial intelligence for detecting small FDG-positive lung nodules in digital PET/CT: impact of image reconstructions on diagnostic performance.
    Schwyzer M; Martini K; Benz DC; Burger IA; Ferraro DA; Kudura K; Treyer V; von Schulthess GK; Kaufmann PA; Huellner MW; Messerli M
    Eur Radiol; 2020 Apr; 30(4):2031-2040. PubMed ID: 31822970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Penalized-Likelihood Estimation Reconstruction on a Digital Time-of-Flight PET/CT Scanner for
    Lindström E; Sundin A; Trampal C; Lindsjö L; Ilan E; Danfors T; Antoni G; Sörensen J; Lubberink M
    J Nucl Med; 2018 Jul; 59(7):1152-1158. PubMed ID: 29449445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced count pediatric whole-body
    Alves VPV; Ata NA; MacLean J; Sharp SE; Li Y; Brady S; Trout AT
    Pediatr Radiol; 2024 Jan; 54(1):170-180. PubMed ID: 37962603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of a block sequential regularized expectation maximization reconstruction algorithm in 18F-FDG PET/CT studies.
    Sah BR; Stolzmann P; Delso G; Wollenweber SD; Hüllner M; Hakami YA; Queiroz MA; Barbosa FG; von Schulthess GK; Pietsch C; Veit-Haibach P
    Nucl Med Commun; 2017 Jan; 38(1):57-66. PubMed ID: 27755394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative CT density histogram values and standardized uptake values of FDG-PET/CT with respiratory gating can distinguish solid adenocarcinomas from squamous cell carcinomas of the lung.
    Tsubakimoto M; Yamashiro T; Tamashiro Y; Murayama S
    Eur J Radiol; 2018 Mar; 100():108-115. PubMed ID: 29496067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved detection of in-transit metastases of malignant melanoma with BSREM reconstruction in digital [
    Liberini V; Messerli M; Husmann L; Kudura K; Grünig H; Maurer A; Skawran S; Orita E; Pizzuto DA; Deandreis D; Dummer R; Mangana J; Mihic-Probst D; Rupp N; Huellner MW
    Eur Radiol; 2021 Oct; 31(10):8011-8020. PubMed ID: 33768288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Bayesian penalized likelihood reconstruction on quantitative and qualitative aspects for pulmonary nodule detection in digital 2-[
    Lohaus N; Enderlin F; Skawran S; Maurer A; Abukwaik AMA; Franzen D; Huellner MW; Messerli M
    Sci Rep; 2022 May; 12(1):8308. PubMed ID: 35585129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative performance and optimal regularization parameter in block sequential regularized expectation maximization reconstructions in clinical
    Ter Voert EEGW; Muehlematter UJ; Delso G; Pizzuto DA; Müller J; Nagel HW; Burger IA
    EJNMMI Res; 2018 Jul; 8(1):70. PubMed ID: 30054750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of Bayesian penalized likelihood reconstruction for improving lesion conspicuity of malignant lung tumors on
    Kurita Y; Ichikawa Y; Nakanishi T; Tomita Y; Hasegawa D; Murashima S; Hirano T; Sakuma H
    Ann Nucl Med; 2020 Apr; 34(4):272-279. PubMed ID: 32060780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative and Qualitative Improvement of Low-Count [
    Seo Y; Khalighi MM; Wangerin KA; Deller TW; Wang YH; Jivan S; Kohi MP; Aggarwal R; Flavell RR; Behr SC; Evans MJ
    Mol Imaging Biol; 2020 Feb; 22(1):208-216. PubMed ID: 30993558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regularized reconstruction of digital time-of-flight
    Lindström E; Velikyan I; Regula N; Alhuseinalkhudhur A; Sundin A; Sörensen J; Lubberink M
    Theranostics; 2019; 9(12):3476-3484. PubMed ID: 31281491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological subtypes of lung adenocarcinoma have differential ¹⁸F-fluorodeoxyglucose uptakes on the positron emission tomography/computed tomography scan.
    Chiu CH; Yeh YC; Lin KH; Wu YC; Lee YC; Chou TY; Tsai CM
    J Thorac Oncol; 2011 Oct; 6(10):1697-703. PubMed ID: 21869716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difference in prognostic values of maximal standardized uptake value on fluorodeoxyglucose-positron emission tomography and cyclooxygenase-2 expression between lung adenocarcinoma and squamous cell carcinoma.
    Shimizu K; Maeda A; Yukawa T; Nojima Y; Saisho S; Okita R; Nakata M
    World J Surg Oncol; 2014 Nov; 12():343. PubMed ID: 25392182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials.
    Weber WA; Gatsonis CA; Mozley PD; Hanna LG; Shields AF; Aberle DR; Govindan R; Torigian DA; Karp JS; Yu JQ; Subramaniam RM; Halvorsen RA; Siegel BA; ;
    J Nucl Med; 2015 Aug; 56(8):1137-43. PubMed ID: 25908829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between FDG-PET/CT findings and solid type non-small cell cancer prognostic factors: are there differences between adenocarcinoma and squamous cell carcinoma?
    Ito R; Iwano S; Kishimoto M; Ito S; Kato K; Naganawa S
    Ann Nucl Med; 2015 Dec; 29(10):897-905. PubMed ID: 26342592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients.
    Lasnon C; Desmonts C; Quak E; Gervais R; Do P; Dubos-Arvis C; Aide N
    Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):985-96. PubMed ID: 23564036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a Bayesian penalized likelihood reconstruction algorithm on image quality in novel digital PET/CT: clinical implications for the assessment of lung tumors.
    Messerli M; Stolzmann P; Egger-Sigg M; Trinckauf J; D'Aguanno S; Burger IA; von Schulthess GK; Kaufmann PA; Huellner MW
    EJNMMI Phys; 2018 Sep; 5(1):27. PubMed ID: 30255439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
    Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP
    Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability of Quantitative 18F-FDG PET/CT Imaging Biomarkers for Classifying Early Response to Chemoradiotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer.
    Horn KP; Thomas HMT; Vesselle HJ; Kinahan PE; Miyaoka RS; Rengan R; Zeng J; Bowen SR
    Clin Nucl Med; 2021 Nov; 46(11):861-871. PubMed ID: 34172602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.